ArticleThe Journal of dermatology2024

Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study.

Mario Valenti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.